Clinical trial · Interventional
Fatigue Intervention Co-design Study in Teenagers and Young Adults With Cancer
NCT02719561CI-TRIAL-00027718completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Fatigue is one of the most common and distressing symptoms in teenage and young adult cancer patients. Despite this, there has been virtually no research evaluating treatment for cancer-related fatigue in this young patient group. The investigators are undertaking a small qualitative study to co-design a fatigue intervention, that will then be evaluated in future research to assess its effectiveness.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Fatigue | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Fatigue Intervention | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Fatigue intervention
- description
- Fatigue Intervention is to be co-designed by participants, and likely to include education, energy conservation and activity promotion. Participants will also decide the name of the Fatigue Intervention
- interventionNames
- Behavioral: Fatigue Intervention
Primary outcomes (2)
- measure
- Participant-reported feedback on design content as assessed via interviews
- timeFrame
- 3 months
- measure
- Participant-reported feedback on design acceptability as assessed via interviews
- timeFrame
- 3 months
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 16 Years
- Maximum age
- 27 Years
Show eligibility criteria text
Inclusion Criteria: Patients: * Aged 16-27 with a diagnosis of cancer * Currently or previously known to the Cambridge Teenage and Young Adult cancer service * Primary cancer treatment completed within one year of recruitment OR on maintenance treatment for leukaemia. * A screening score of ≥5 in a 10-item numerical rating scale of fatigue severity over the last month * Able to give informed consent Parents: * The parent of a patient participant or a patient who would be eligible to participate * The patient consents to the parent being approached about the study * The parent is able to give informed consent Exclusion Criteria: * Current participation in another clinical trial
References
Publications (0)
Data not yet available
No reference posted for this study.